# Zycubo

NDC: 42358-329
Generic name: copper histidinate
Labeler / Manufacturer: Sentynl Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260112

FDA application: NDA211241

## Active ingredients

- COPPER HISTIDINATE: 2.9 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42358-329"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42358-329
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3aeefc2-f44d-4337-9c2e-3dba44a89e48